DIADEMA PARTNERS LP
Q2 2025 13F Holdings
- Locationmorristown, NJ
- Num holdings
95
- Value ($000)
$328,219
- Date Filed08/14/2025
- Form type13F-HR
- CIK0002026172
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS INC | COM | 834203309 | $23.81 M | 7 % | 284,152 | ||
AMGN AMGEN INC | COM | 031162100 | $17.34 M | 5 % | 62,100 | put | |
LLY ELI LILLY & CO | COM | 532457108 | $16.14 M | 5 % | 20,700 | put | |
AMGN AMGEN INC | COM | 031162100 | $14.55 M | 4 % | 52,100 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $13.37 M | 4 % | 371,448 | ||
NBIX NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $11.82 M | 4 % | 94,042 | ||
LLY ELI LILLY & CO | COM | 532457108 | $11.55 M | 4 % | 14,816 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $11.09 M | 3 % | 104,473 | ||
BMRN BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | $10.60 M | 3 % | 192,877 | ||
KRE SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | $8.29 M | 3 % | 100,000 | call |
Rows Per Page
10
- 10
- 50
- 100